Unresolved issues in medical science: Spain leads the way in clinical trials, but only 8 per cent reach primary care
Doctors and the industry are calling for a push to boost clinical research in healthcare centres in order to optimise treatments for the most common conditions and bring cutting-edge medicine closer to patients elmundo.es Jesús González, a GP at the Cabra Health Centre (Córdoba), highlights a paradox that exists in the field of clinical trials […]
ICON joins forces with Microsoft to revolutionise clinical trials using artificial intelligence
The Irish multinational will implement Microsoft Copilot and Azure to optimise the design of clinical trials and accelerate drug development consalud.es This week, the Irish company ICON, which specialises in contract research organisation (CRO) services, announced a technology partnership with Microsoft as part of its strategy to increase investment in artificial intelligence over the next […]
The pharmaceutical industry is warning Europe that it will lose investment if it does not pay more for innovative medicines
The EFPIA president points out that US pricing policy is putting pressure on the continent and warns that the sector will cut back on manufacturing and clinical trials if profit margins are reduced Consalud.es The president of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Stefan Oelrich, has issued a statement in which he […]
US speeds up clinical trials: the biotechnology industry calls on the FDA to standardise the drug approval process
Following the announcement of a plan to speed up clinical trials in the face of competition from China, the sector is calling for an end to the uncertainty and for the evaluation of new drugs to be standardised consalud.es The Biotechnology Innovation Organisation (BIO), the leading advocacy group for the biotechnology industry in the US, […]
Pharmaceutical innovation has seen its investment in Europe increase fivefold, with a profit of 66,000 million
A new study by the European Federation of Pharmaceutical Industries and Associations (EFPIA) shows that the introduction of new treatments frees up more than 57,000 hospital beds and generates net savings of 9,000 million euros in just one year consalud.es The European Federation of Pharmaceutical Industries and Associations (EFPIA) has taken a step forward in […]
Biomedical research in Spain: between leadership, bureaucratic red tape and the challenge of data management
The panel ‘Science for Life: Research in the Service of Health’ brought the 1st Impact Forum to a close, with the aim of understanding how innovation serves the public Tercera mesa del I Foro Impacto eldiario.es The ‘1st Impact Forum: Innovation with a Purpose’ event, organised by elDiario.es, concluded with a panel discussion that examined […]
Spain can take the decisive leap forward in biomedical research: from a scientific powerhouse to a global leader
The 19th Conference of Biomedical Research Technology Platforms brings together more than 200 representatives from public administrations, universities, patient groups and businesses in Barcelona Experts stress that Spain’s research ecosystem needs to continue making progress in cooperation, knowledge transfer and business development, with the aim of generating innovation that has an impact on patients’ health […]
The time taken to gain access to new medicines has fallen to 537 days, although this is still far from the 180-day limit set by the European Directive
The WAIT 2025 Report shows that Spanish patients have access to 69% of new medicines authorised in Europe, yet only 47% of these are available without restrictions In a geopolitical context of great uncertainty, predictability is a key factor in competitiveness. A process characterised by long and unpredictable timelines, opaque rules, or negotiations focused exclusively […]
+ensayos is launched: a platform designed to highlight the importance of clinical trials and the people who make them possible
To mark International Clinical Trials Day, Farmaindustria and 18 member companies are launching an open and collaborative initiative supported by the Ministry of Health, the Aemps, the ISCIII, the Catalan Department of Health and more than thirty organisations from the research ecosystem The project kicks off with a promotional video, interviews with key figures involved […]
Clinical trials for rare diseases have increased by 4% in Spain, with Catalonia, Madrid and Andalusia leading the way
The Spanish Association of Orphan and Ultra-Orphan Drug Laboratories has published its annual report, which analyses the most relevant data on clinical trials authorised for these conditions consalud.es The Spanish Association of Laboratories for Orphan and Ultra-Orphan Medicines (AELMHU) has published the ‘Report on Clinical Trials for Rare Diseases in Spain 2025’, which analyses the […]
ES
EN